Efti + KEYTRUDA combo shows strong efficacy for NSCLC patients in Immutep's phase 1 study. Read why IMMP stock may see upside ...

Lynn Hunt, from the UK, Initially thought she had just ‘bitten’ her tongue when two little white spots appeared on the side, ...

Full House alum Dave Coulier posted a photo of himself undergoing chemotherapy, two days after sharing that he was battling ...

A study published inClinical Cancer Research found that in patients with unresectable, locally advanced esophageal cancer, ...

In patients with unresectable, locally advanced esophageal cancer, the triple combination of radiation, chemotherapy, and immunotherapy made tumors more amenable to surgery, which was associated with ...

Yanghee Woo, MD, discusses the details and lasting impact of the CROSS trial in the treatment of gastroesophageal junction ...

During a Case-Based Roundtable® event, Patrick M. Forde, MD, discussed safety and tolerability concerns with immunotherapy in ...

Aaron Whittington was young, fit and healthy when he was diagnosed. Picture: Lachie Millard But after there was no ...

Cells in the head and neck are especially vulnerable to air pollution, including tobacco smoke, which contains numerous ...

Emrosi approved by FDA on November 4 for the treatment of inflammatory lesions of rosacea in adultsCosibelimab PDUFA goal date of December 28 for ...

“We are currently on track to achieve several anticipated milestones, most notably the upcoming initiation of FORTIFI-HN01, a pivotal Phase 2/3 trial of ficerafusp alfa, for the treatment of recurrent ...